Investors sold shares of UnitedHealth Group Incorporated (NYSE:UNH) on strength during trading on Friday. $112.01 million flowed into the stock on the tick-up and $145.98 million flowed out of the stock on the tick-down, for a money net flow of $33.97 million out of the stock. Of all companies tracked, UnitedHealth Group had the 0th highest net out-flow for the day. UnitedHealth Group traded up $0.16 for the day and closed at $198.06

UNH has been the subject of a number of research analyst reports. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $208.00 price target on shares of UnitedHealth Group in a report on Friday, July 21st. ValuEngine raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Friday, September 1st. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Oppenheimer Holdings, Inc. reissued an “outperform” rating and issued a $205.00 price objective (up from $203.00) on shares of UnitedHealth Group in a report on Friday, July 21st. Finally, BidaskClub downgraded UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a report on Wednesday, July 19th. Three investment analysts have rated the stock with a hold rating and twenty-three have issued a buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $203.59.

The company has a market capitalization of $191.50 billion, a PE ratio of 23.79 and a beta of 0.63. The firm has a 50 day moving average of $196.36 and a 200 day moving average of $183.56.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The business had revenue of $50.05 billion during the quarter, compared to analyst estimates of $49.97 billion. During the same quarter in the previous year, the firm posted $1.96 EPS. The business’s revenue for the quarter was up 7.7% compared to the same quarter last year. On average, analysts anticipate that UnitedHealth Group Incorporated will post $9.87 EPS for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 19th. Investors of record on Friday, September 8th were given a dividend of $0.75 per share. The ex-dividend date of this dividend was Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a yield of 1.51%. UnitedHealth Group’s dividend payout ratio is currently 35.13%.

In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,600 shares of the business’s stock in a transaction on Tuesday, September 5th. The stock was sold at an average price of $199.49, for a total transaction of $1,117,144.00. Following the completion of the transaction, the director now owns 60,834 shares in the company, valued at approximately $12,135,774.66. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Larry C. Renfro sold 50,574 shares of the business’s stock in a transaction on Friday, September 15th. The stock was sold at an average price of $198.11, for a total value of $10,019,215.14. Following the transaction, the insider now owns 195,625 shares of the company’s stock, valued at approximately $38,755,268.75. The disclosure for this sale can be found here. Insiders have sold a total of 76,174 shares of company stock valued at $14,981,909 in the last 90 days. Insiders own 0.89% of the company’s stock.

A number of hedge funds have recently made changes to their positions in UNH. Harbour Capital Advisors LLC boosted its position in UnitedHealth Group by 18,383.4% during the 2nd quarter. Harbour Capital Advisors LLC now owns 2,516,706 shares of the healthcare conglomerate’s stock worth $13,573,000 after acquiring an additional 2,503,090 shares during the period. Janus Henderson Group PLC boosted its position in UnitedHealth Group by 1,820.1% during the 2nd quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock worth $442,896,000 after acquiring an additional 2,264,242 shares during the period. Vanguard Group Inc. boosted its position in UnitedHealth Group by 2.5% during the 2nd quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after acquiring an additional 1,588,516 shares during the period. Parametric Portfolio Associates LLC boosted its position in UnitedHealth Group by 77.3% during the 2nd quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock worth $664,570,000 after acquiring an additional 1,562,661 shares during the period. Finally, Jennison Associates LLC boosted its position in UnitedHealth Group by 180.4% during the 2nd quarter. Jennison Associates LLC now owns 2,252,507 shares of the healthcare conglomerate’s stock worth $417,660,000 after acquiring an additional 1,449,130 shares during the period. Institutional investors own 86.19% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Investors Sell UnitedHealth Group Incorporated (UNH) on Strength (UNH)” was reported by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another website, it was stolen and reposted in violation of U.S. and international copyright and trademark legislation. The original version of this piece can be viewed at https://www.dailypolitical.com/2017/10/08/investors-sell-unitedhealth-group-incorporated-unh-on-strength-unh-3.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.